Featured Content

Articles

Study Suggests Timing of Immunotherapy Could Impact Clinical Outcomes

A systematic review in JAMA Network Open suggests earlier administration of immune checkpoint inhibitor therapies may improve survival outcomes in patients being treated for late-stage solid tumors. The analysis pooled data from 29 studies encompassing more than 6,000 patients. Earlier timing was linked to gains in both survival endpoints, though prospective validation is required before scheduling adjustments can be broadly adopted.  The studies covered tumor types like melanoma, gastric, renal … Continue reading “Study Suggests Timing of Immunotherapy Could Impact Clinical Outcomes”

TinyGemsBreaks

TinyGemsBreaks – Kairos Pharma Ltd. (NYSE American: KAPA) Sets Virtual Annual Meeting, Discloses Going Concern Notice

Kairos Pharma (NYSE American: KAPA) announced that its annual meeting of shareholders will be held virtually at 9 a.m. PDT on June 29, 2026, with meeting materials to be mailed following finalization and filing with the SEC. The clinical-stage biopharmaceutical company also disclosed that its 2025 annual report included an audit report containing a going … Continue reading “TinyGemsBreaks – Kairos Pharma Ltd. (NYSE American: KAPA) Sets Virtual Annual Meeting, Discloses Going Concern Notice”

Sector News

Filter Releases
Sectors



Symbol Release Time Source
{{ release.qmtopics.qmsymbol[0].symbol }} {{ release.headline }} {{ release.datetime | amDateFormat:'hh:mm A'}} {{ release.source }}

NewsRoom

Receive Alerts from TinyGems

Text "Gems" to 888-902-4192

(US Mobile Phones Only)

About TinyGems

Discover diamonds in the rough with TinyGems.

TinyGems spotlights emergent small-cap companies with bright futures and big potential. Small and yet unproven, there’s obvious risk but also huge upside possibilities for investors in the know. Contrary to conventional dogma, shares of small-cap and mid-cap companies posted far superior total returns than mega-cap stocks since December 1999.

Don’t overlook the innovation of disruptive small-cap companies on the cusp of market discovery. TinyGems puts a spotlight on the best and brightest of these disruptors that have the technology, the talent, the drive, and the business models to make a huge impact in the markets and in portfolios.

More About TinyGems    Schedule a Live Online Demo

Contact us: (512) 354-7000